STOCK TITAN

Galexxy Holdings Inc - GXXY STOCK NEWS

Welcome to our dedicated news page for Galexxy Holdings (Ticker: GXXY), a resource for investors and traders seeking the latest updates and insights on Galexxy Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Galexxy Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Galexxy Holdings's position in the market.

Rhea-AI Summary
Galexxy Holdings Inc. redirects resources to the Functional Mushroom Market, divesting from CBD and Hemp businesses. The company positions itself to capitalize on the growing demand for functional mushrooms, focusing on Wellbeing Farms and Galexxy LLC. Galexxy plans to expand in the direct-selling market, aiming for long-term sustainability and shareholder value maximization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.45%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings Inc. and Hussle.Tech have agreed to integrate the Verb and Hussle app technologies with the new Galexxy Sales App to power the Galexxy direct sales channel. The new app is expected to bring new revenues through increased clicks to the website and engagement. Galexxy aims to create a new $69 billion marketplace by 2030. The integration of Hussle technology will provide tools for building individual businesses, communication, training, and more. Galexxy's leaders will have new functional mushroom products to sell backed by real-time payment recognition and billing technology. The targeted pre-launch is scheduled for this quarter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.94%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings announces the appointment of Trent D'Ambrosio as VP of Sales and Marketing, aiming to expand retail and wholesale sales programs. Trent's leadership experience is expected to drive rapid sales growth and open new distribution channels. Galexxy's CEO expresses enthusiasm for Trent's appointment. Trent highlights the potential growth in the health and wellness industry and sees Galexxy as an excellent fit with emerging global market trends. Galexxy's shares are publicly traded on OTC Markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.57%
Tags
none
Rhea-AI Summary
VendGenie expands agreement with Delta 88, revenue forecast increased to $12.75m in year two
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings outlines forecasted revenue sources for 2024, including $7.5m from Wellbeing Farms, $10m from Galexxy LLC, and $3m from VendGenie's agreement with Delta 88. ABC Holdings anticipates a 2x increase in AVALOO sales revenue. Galexxy LLC specializes in direct-to-consumer sales of functional mushroom supplements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.73%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings signs joint venture with Pillars International, introducing new Direct Sales Company called Galexxy LLC. Ambassadors will sell functional mushroom products with new payment and billing platform. Targeted pre-launch this 4th quarter. Galexxy has controlling interest in Galexxy LLC. Positive opportunity in the market. Joint venture caught interest of key leaders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.01%
Tags
none
Galexxy Holdings Inc

OTC:GXXY

GXXY Rankings

GXXY Stock Data

12.92M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Newport Beach